Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

PROTECT-APT 1 Study

Early Treatment and Post-Exposure Prophylaxis of COVID-19 - Adaptive Platform Trial (PROTECT-APT 1)

woman taking her temperature
AGE: 18+ years old
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: No
TYPE: Interventional Study
CONDITION: SARS-CoV-2, COVID
LOCATIONS: UH Cleveland Medical Center and other locations

Study Purpose

The purpose of this research study is to test the ability of an investigational study drug to shorten and reduce a COVID-19 infection. In addition, researchers will study how well the study drug works against the virus that causes COVID-19 and continue to monitor the safety of the study drug.

Who Can Participate

Participants 18 years and older diagnosed with COVID be eligible for this study.

Request More Information

Please complete the form below to be contacted by a study representative and learn more about this study,

I'm not a robot

  • 2024-01447